Clinical Trial

Effects of Blood Flow Restriction Exercises on Lumbar Muscle Endurance and Balance in Healthy Young Adults

Study acronym: BFR-LUMBEX
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 19, 2025 (before its estimated November 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to examine the effects of blood flow restriction (BFR) exercises on back muscle endurance and balance in healthy young adults. BFR is a training method that involves applying controlled pressure to the limbs with a cuff while performing simple exercises. It has been shown to improve muscle strength and endurance even at low exercise loads, reducing stress on the joints. In this study, participants aged 20 to 25 years will be randomly assigned to two groups. One group will perform sit-to-stand (STS) exercises combined with BFR, while the other group will perform the same exercises without BFR. The exercise program will last 6 weeks, with 2 sessions per week. Before and after the program, participants will be assessed for: Lumbar extensor muscle endurance (using the Biering-Sørensen test) Balance performance (using a computerized balance platform) Physiological responses such as oxygen saturation, heart rate, and blood pressure The purpose of this research is to determine whether BFR exercises improve spinal muscle endurance and balance more effectively than standard sit-to-stand exercises. The results may provide new insights into the use of BFR training as a safe and practical strategy for improving posture, preventing back problems, and enhancing physical performance in young adults.
Trial Details
NCT Number NCT07182812
Lead Sponsor Mehmet Akif Guler
Collaborators: The Scientific and Technological Research Council of Turkey
Conditions Healthy Volunteers, Low Back Pain, Postural Balance, Muscle Fatigue, Endurance
Enrollment 70 participants
Start Date 2025-09-29
Primary Completion 2025-11-30 (estimated)
Study Completion 2025-11-30 (estimated)
Updated on ClinicalTrials.gov 2025-09-19